Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma

被引:0
|
作者
Michael Ozga
Qiuhong Zhao
Laila Huric
Cecelia Miller
Ashley Rosko
Abdullah Khan
Elvira Umyarova
Don Benson
Francesca Cottini
机构
[1] The Ohio State University Comprehensive Cancer Center,
[2] Department of Internal Medicine,undefined
[3] Division of Hematology,undefined
[4] The Ohio State University Comprehensive Cancer Center,undefined
[5] Department of Pathology,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 23 条
  • [1] Concomitant 1q+and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
    Ozga, Michael
    Zhao, Qiuhong
    Huric, Laila
    Miller, Cecelia
    Rosko, Ashley
    Khan, Abdullah
    Umyarova, Elvira
    Benson, Don
    Cottini, Francesca
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [2] Tandem Autologous Transplantation Can Overcome the Poor Prognosis of Double-Hit Multiple Myeloma Patients With 1q21 Gain/Amp and t(4;14)
    Huang, Beihui
    Li, Juan
    Wang, Xiuju
    Huang, Hongming
    Xu, Xiaojun
    Wu, Bingyi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S229 - S229
  • [4] A Rare Case of Triple-Hit Ultra-High-Risk Multiple Myeloma Harboring t(4;14), t(14;20), and Gain(1q)
    Lu, Jiao
    Wang, Qian
    Wang, Jing
    Zeng, Zhao
    Shi, Xiaolan
    Liu, Dandan
    Chen, Suning
    Yan, Lingzhi
    Fu, Chengcheng
    Pan, Jinlan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025,
  • [5] 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib
    Du, Chenxing
    Mao, Xuehan
    Xu, Yan
    Yan, Yuting
    Yuan, Chenglu
    Du, Xin
    Liu, Jiahui
    Fan, Huishou
    Wang, Qi
    Sui, Weiwei
    Deng, Shuhui
    Fu, Mingwei
    Li, Zengjun
    Li, Chengwen
    Zhao, Jiawei
    Yi, Shuhua
    Liu, Lanting
    Hao, Mu
    Zou, Dehui
    Zhao, Yaozhong
    Qiu, Lugui
    An, Gang
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1201 - 1210
  • [6] 1q21 Gain May Challenge the Role of t(4;14) As an Adverse Prognostic Marker of Multiple Myeloma
    Du, Chenxing
    Gang, An
    Xu, Yan
    Mao, Xuehan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li Zengjun
    Li, Chengwen
    Yi, Shuhua
    Hao, Mu
    Zou, Dehui
    Zhan, Fenghuang
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    Qiu, Lugui
    BLOOD, 2019, 134
  • [7] The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma
    Akasaka, Takashi
    Kishimori, Chiyuki
    Fukutsuka, Katsuhiro
    Nakagawa, Miho
    Takeoka, Kayo
    Hayashida, Masahiko
    Honjo, Gen
    Ohno, Hitoshi
    CANCER GENETICS, 2017, 214 : 26 - 31
  • [8] Double-Hit Lymphoma Demonstrating t(6;14;18)(p25;q32;q21), Suggesting Two Independent Dual-Hit Translocations, MYC/BCL-2 and IRF4/BCL-2
    Tabata, Rie
    Yasumizu, Ryoji
    Tabata, Chiharu
    Kojima, Masaru
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 141 - 150
  • [9] Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization
    Finelli, P
    Fabris, S
    Zagano, S
    Baldini, L
    Intini, D
    Nobili, L
    Lombardi, L
    Maiolo, AT
    Neri, A
    BLOOD, 1999, 94 (02) : 724 - 732
  • [10] Detection of the t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
    Neri, A
    Finelli, P
    Fabris, S
    Zagano, S
    Baldini, L
    Nobili, L
    Lombardi, L
    Maiolo, AT
    BLOOD, 1998, 92 (10) : 259A - 259A